References
1. Tayeb A.H., Tajvidi M. Sustainable barrier system via self-assembly 8. of colloidal montmorillonite and cross-linking resins on nanocellulose interfaces. ACS Appl Mater Interfaces. 2019; 11 (1): 1604-15. DOI: 10.1021/acsami.8b16659.
2. Razgovorova M.P., Selyavin A.V., Razgovorov P.B. The use of clays of various compositions for the separation of impurities of vegetable 9. oils. Uspekhi v khimii i khimicheskoy tekhnologii [Advances in Chemistry and Chemical Technology]. 2011; (25): 119-21. (in Russian)
3. Abdel-Wahhab M.A., El-Nekeety A.A., Hathout A.S., Sabery B.A., Ibrahim M.I., Gado R.A., et al. Preparation and characterization of organo-modified nano montmorillonite and evaluation of its ability to adsorb aflatoxins, fumonisins and zearalenone from aqueous solution. Nano Sci Tech Open Lib. 2015; 1 (1): 27-34.
4. Abrahams P.W., Davies T.C., Solomon A.O., Trow A.J., Wragg J. Human geophagia, calabash chalk and undongo: mineral element nutritional implications. PLoS One. 2013; 8 (1): e53304. DOI: 10.1371/journal.pone.005330.
5. Afriyie-Gyawu E., Wang Z., Ankrah N.A., Xu L., Johnson N.M., Tang L., et al. NovaSil clay does not affect the concentrations of vitamins A and E and nutrient minerals in serum samples from Ghanaians at high risk for aflatoxicosis. Food Addit Contam Part A. 2008; 25: 872-84. DOI: 10.1080/02652030701854758.
6. Rodrigues L.A., Figueiras A., Veiga F., de Freitas R.M.., Nunes L.C., da Silva Filho E.C., et al. The systems containing clays and clay minerals from modified drug release: a review. Colloids Surf B Biointerfaces. 2013; 103: 642-51. DOI: 10.1016/j.colsurfb.2012.10.068.
7. Akbari Alavijeh M., Sarvi M.N., Ramazani Afarani Z. Properties of adsorption of vitamin B12 on nanoclay as a versatile carrier. Food Chem. 2017; 219: 207-14. DOI: 10.1016/j.foodchem.2016.09.140.
8. Jorda- Beneyto M., Ortuno N., Devis A., Aucejo S., Puerto M., Gutierrez-Praena D., et al. Use of nanoclay platelets in food packaging materials: technical and cytotoxity approach. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014; 31 (3): 354-64. DOI: 10.1080/19440049.2013.874045.
9. Vergaro V., Abdullayev E., Lvov Y.M., Zeitoun A., Cingolani R., Rinaldi R., et al. Cytocompatibility and uptake of halloysite clay nanotubes. Biomacromolecules. 2010; 11 (3): 820-6. DOI: 10.1021/ bm9014446.
10. Maisanaba S., Pichardo S., Puerto M., Gutierrez-Praena D., Cam-ean A.M., Jos A. Toxicological evaluation of clay minerals and derived nanocomposites: a review. Environ Res. 2015; 138: 233-54. DOI: 10.1016/j.envres.2014.12.024.
11. Moosavi M. Bentonite clay as a natural remedy: a brief review. Iran J Public Health. 2017; 46 (9): 1176-83. PMCID: PMC5632318.
12. Kibanova D., Nieto-Camacho A., Cervini-Silva J. Lipid peroxidation induced by expandable clay minerals. Environ Sci Technol. 2009; 43 (19): 7550-5. DOI: 10.1021/es9007917.
13. EFSA. European Food Safety Authority. Scientific opinion on the safety and efficacy of a preparation of bentonite- and sepiolite (Toxfin Dry) as feed additive for all species. EFSA J. 2013; 11 (4): 1-21. DOI: 10.2903/j.efsa.2013.3179.
14. Smirnova VV., Tananova O.N., Shumakova A.A., Trushina E.N., Avrenyeva L.I., Bykova I.B., et al. Toxicological and hygienic characteristics of nanostructured bentonite clay. Gigiyena i sanitariya [Hygiene and Sanitation]. 2012; (3): 76-8. (in Russian)
15. Loskutova L.V., Dubrovina N.I., Markel’ A.L. Comparative analysis of the persistence of a conditioned passive avoidance reflex in rats with different forms of inherited hypertension. Neurosci Behav Physiol. 2007; 37 (6): 577-82.
16. Stuart C.A., Twistelton R., Nicholas M.K., Hide D.W. Passage of cow’s milk proteins in breast milk. Clin Allergy. 1984; 14 (6): 533-5.
17. Raspopov R.V., Trushina E.N., Gmoshinskiy I.V., Khotimchenko S.A. Bioavailability of iron oxide nanoparticles when used in food. The results of experiments on rats. Voprosy pitaniya [Problems of Nutrition]. 2011; 80 (3): 25-30. (in Russian)
18. Razygraev A.V. Method for the determination of glutathione peroxidase activity using hydrogen peroxide and 5.5’-dithiobis (2-nitrobenzoic acid). Kliniko-laboratornyy konsilium [Clinical Laboratory Consultation]. 2004; (4): 19-22. (in Russian)
19. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82 (1): 70-7. DOI: 10.1016/0003-9861(59)90090-6.
20. Golubkina N.A. Fluorimetric method for determining selenium. Zhurnal analiticheskoy khimii [Journal of Analytical Chemistry]. 1995; 50 (8): 492-7. (in Russian)
21. Botros M., Sikaris K.A. The de Ritis ratio: the test of time. Clin Biochem Rev. 2013; 34 (3): 117-30.
22. Roslyy I.M. Biochemical indicators in medicine and biology. Moscow: MIA, 2015: 616 p. (in Russian)
23. Murphy E.J., Roberts E., Horrocks L.A. Aluminum silicate toxicity in cell cultures. Neuroscience. 1993; 55 (2): 597-605.
24. Li P.R., Wei J.C., Chiu Y.F., Su H.L. Peng F.C., Lin J.J. Evaluation on cytotoxicity and genotoxicity of the exfoliated silicate nanoclay. ACS Appl Mater Interfaces. 2010; 2: 1608-13. DOI: 10.1021/ am1001162ю
25. Baek M., Lee J.-A., Choi S.-J. Toxicological effects of a cationic clay, montmorillonite in vitro and in vivo. Mol Cell Toxicol. 2012; 8 (1): 95-101. DOI: 10.1007/s13273-012-0012.
26. Verma N.K., Moore E., Blau W., Volkov Y., Babu P.R. Cytotoxicity evaluation of nanoclays in human epithelial cell line A549 using high content screening and real-time impedance analysis. J Nanopart Res. 2012; 14 (9): 1137-48. DOI: 10.1007/s11051-012-1137-5.
27. Zhang M., Li X., Lu Y., Fang X., Chen Q., Xing M., He J. Studying the genotoxic effects induced by two kinds of bentonite particles on human B lymphoblast cells in vitro. Mutat Res. 2011; 720: 62-6. DOI: 10.1016/j.mrgentox.2010.12.009.
28. Zhang M., Lu Y., Li X., Chen Q., Lu L., Xing M., et al. Studying the cytotoxicity and oxidative stress induced by two kinds of bentonite particles on human B lymphoblast cells in vitro. Chem Biol Interact. 2010; 183 (3): 390-6. DOI: 10.1016/j.cbi.2009.11.023.
29. Rawat K., Agarwal S., Tyagi A., Verma A.K., Bohidar H.B. Aspect ratio dependent cytotoxicity and antimicrobial properties of nanoclay. Appl Biochem Biotechnol. 2014; 174 (3): 936-44. DOI: 10.1007/s12010-014-0983-2.
30. Sharma A.K., Schmidt B., Frandsen H., Jacobsen N.R., Larsen E.H., Binderup M.L. Genotoxicity of unmodified and organo-modified montmorillonite. Mutat Res. 2010; 700 (1-2): 18-25. DOI: 10.1016/ j.mrgentox.2010.04.021.
31. Lee Y.H., Kuo T.F., Chen B.Y., Feng Y.K., Wen Y.R., Lin W.C., et al. Toxicity assessment of montmorillonite as a drug carrier for pharmaceutical applications: yeast and rats model. Biomed Eng Appl Basis Commun. 2005; 17: 72-8. DOI: 10.4015/S1016237205000111.
32. Mascolo N., Summa V., Tateo F. In vivo experimental data on the mobility of hazardous chemical elements from clays. Appl Clay Sci. 2004; 25 (1-2): 23-8. DOI: 10.1016/j.clay.2003.07.001.
33. Afriyie-Gyawu E., Mackie J., Dash B., Wiles M., Taylor J., Huebner H., et al. Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley rats. Food Addit Contam. 2005; 22 (3): 259-69. DOI: 10.1080/02652030500110758.
34. Maisanaba S., Gutierrez-Praena D., Puerto M., Moyano R., Blanco A., Jorda M., et al. Effects of the subchronic exposure to organomodified clay for food packaging applications on Wistar rats. Appl Clay Sci. 2014; 95: 37-40. DOI: 10.1016/j.clay.2014.04.006.
35. Maisanaba S., Puerto M., Gutierrez-Praena D., Llana-Ruiz-Cabello M., Pichardo S., Mate A., et al. In vivo evaluation of activities and expression of antioxidant enzymes in Wistar rats exposed for 90 days to a modified clay. J Toxicol Environ Health A. 2014; 77 (8): 456-66. DOI: 10.1080/15287394.2013.876696.
36. Wiles M.W., Huebner H.J., Afriyie-Gyawu E., Taylor R.J., Bratton G.R., Phillips T.D. Toxicological evaluation and metal bioavailability in pregnant rats following exposure to clay minerals in the diet. J Toxicol Environ Health A. 2004; 67 (11): 863-74. DOI: 10.1080/15287390490425777.
37. Sharma A.K., Mortensen A., Schmidt B., Frandsen H., Hadrup N., Larsen E.H., et al. In vivo study of genotoxic and inflammatory effects of the organo-modified montmorillonite Cloisite 30B. Mutat. Res. 2014; 770: 66-71. DOI: 10.1016/j.mrgentox.2014.04.023.
38. Williams L.B., Metge D.W., Eberl D.D., Harvey R.W., Turner A.G., Prapaipong P., et al. What makes a natural clay antibacterial? Environ Sci Technol. 2011; 45 (8): 3768-73. DOI: 10.1021/es1040688.
39. Williams L.B., Haydel S.E. Evaluation of the medicinal use of clay minerals as antibacterial agents. Int Geol Rev. 2010; 52 (7-8): 745-70. DOI: 10.1080/00206811003679737.